Phosphodiesterase 5 inhibitors in vascular systemic disorders

被引：4
|
作者：
Allanore, Yannick [1 ]
机构：
[1] Univ Paris 05, INSERM U1016, Serv Rhumatol, Hop Cochin, F-75014 Paris, France
来源：
JOINT BONE SPINE | 2012年 / 79卷 / 04期
关键词：
Phosphodiesterase; Nitric oxide; Pulmonary hypertension; Raynaud's phenomenon; Sildenafil; Tadalafil; PULMONARY ARTERIAL-HYPERTENSION; RAYNAUDS-PHENOMENON RESISTANT; DOUBLE-BLIND; SILDENAFIL; THERAPY; TADALAFIL; SCLEROSIS; EFFICACY;
D O I：
10.1016/j.jbspin.2011.12.009
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：338 / 340
页数：3
相关论文
共 50 条
  • [21] Phosphodiesterase 5 inhibitors for erectile dysfunction
    Setter, SM
    Iltz, JL
    Fincham, JE
    Campbell, RK
    Baker, DE
    ANNALS OF PHARMACOTHERAPY, 2005, 39 (7-8) : 1286 - 1295
  • [22] A review of phosphodiesterase type 5 inhibitors
    Schellack, N.
    Agoro, A.
    SOUTH AFRICAN FAMILY PRACTICE, 2014, 56 (02) : 96 - 101
  • [23] Cardiovascular effects of phosphodiesterase 5 inhibitors
    Reffelmann, Thorsten
    Kloner, Robert A.
    CURRENT PHARMACEUTICAL DESIGN, 2006, 12 (27) : 3485 - 3494
  • [24] Advances in the development of phosphodiesterase 5 inhibitors
    Zong, Tieqiang
    Huang, Xing
    Zhou, Wei
    Hu, Zhengyu
    Jin, Long
    Zhan, Peng
    Zhao, Yuqing
    Sun, Jinfeng
    Li, Gao
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2025, 287
  • [25] Phosphodiesterase-5-inhibitors compared
    不详
    AKTUELLE UROLOGIE, 2005, 36 (01)
  • [26] Phosphodiesterase-5 inhibitors and migraine
    Evans, RW
    Kruuse, C
    HEADACHE, 2004, 44 (09): : 925 - 926
  • [27] Evolution of Phosphodiesterase-5 Inhibitors
    Moon, Du Geon
    WORLD JOURNAL OF MENS HEALTH, 2015, 33 (03): : 123 - +
  • [28] PHOSPHODIESTERASE INHIBITORS IN THE TREATMENT OF VASCULAR DYSFUNCTION IN PATIENTS WITH COLLAGEN VASCULAR DISEASES
    Popescu, M.
    Tanaseanu, C.
    Tanaseanu, S.
    Dumitrascu, A.
    Tiglea, I.
    Moldoveanu, E.
    Marta, D.
    RHEUMATOLOGY, 2012, 51 : 69 - 69
  • [29] LONG ACTING PHOSPHODIESTERASE 5 INHIBITION WITH TADALAFIL: A NOVEL TREATMENT FOR VASCULAR MANIFESTATIONS OF SYSTEMIC SCLEROSIS
    Malaviya, Anshuman P.
    Dasgupta, Bhaskar
    RHEUMATOLOGY, 2010, 49 : I42 - I42
  • [30] PHOSPHODIESTERASE INHIBITORS AS ANTIPLATELET AGENTS IN VASCULAR-SURGERY
    KAMBAYASHI, J
    WATASE, M
    KAWASAKI, T
    SHIBA, E
    SAKON, M
    MORI, T
    ISAKA, Y
    KIMURA, K
    KAMADA, T
    ADVANCES IN SECOND MESSENGER AND PHOSPHOPROTEIN RESEARCH, 1992, 25 : 383 - 393
12345